These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 14506146

  • 1. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH, Offerhaus GJ, van Puijenbroek M, Caspers E, Gruis NA, De Snoo FA, Lamers CB, Griffioen G, Bergman W, Vasen HF, Morreau H.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A.
    Br J Cancer; 2001 Jan 01; 84(2):253-62. PubMed ID: 11161385
    [Abstract] [Full Text] [Related]

  • 4. Abnormalities of tumor suppressor gene p16 in pancreatic carcinoma: immunohistochemical and genetic findings compared with clinicopathological parameters.
    Ohtsubo K, Watanabe H, Yamaguchi Y, Hu YX, Motoo Y, Okai T, Sawabu N.
    J Gastroenterol; 2003 Jan 01; 38(7):663-71. PubMed ID: 12898359
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Biallelic inactivation of the p16-Gen in a metachronous triple carcinoma in the oropharyngeal region].
    Motsch C, Giers A, Boltze C, Evert M, Freigang B, Roessner A, Schneider-Stock R.
    Laryngorhinootologie; 2004 Jan 01; 83(1):55-60. PubMed ID: 14740307
    [Abstract] [Full Text] [Related]

  • 7. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
    Moskaluk CA, Hruban RH, Kern SE.
    Cancer Res; 1997 Jun 01; 57(11):2140-3. PubMed ID: 9187111
    [Abstract] [Full Text] [Related]

  • 8. [Study on the relationship of alteration and expression of p16 gene to pancreatic carcinoma].
    Zhou J, Yang D, Zhang L, Wang J, Yao Q, Su Z, Fan Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec 01; 17(6):399-403. PubMed ID: 11110976
    [Abstract] [Full Text] [Related]

  • 9. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ, Chen J, Liu TH, Cui QC, Lu ZH, Li L, Gao J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr 08; 24(2):165-9. PubMed ID: 12905795
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S.
    Ann Surg; 2013 Aug 08; 258(2):336-46. PubMed ID: 23470568
    [Abstract] [Full Text] [Related]

  • 14. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A, Thirumaran RK, Ugurel S, Gast A, Hemminki K, Kumar R, Schadendorf D.
    Arch Dermatol; 2007 Apr 08; 143(4):495-9. PubMed ID: 17438182
    [Abstract] [Full Text] [Related]

  • 15. Tumor-suppressive pathways in pancreatic carcinoma.
    Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ, Kern SE.
    Cancer Res; 1997 May 01; 57(9):1731-4. PubMed ID: 9135016
    [Abstract] [Full Text] [Related]

  • 16. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK, Zanation AM, Moss JR, Yarbrough WG.
    Laryngoscope; 2002 Sep 01; 112(9):1587-93. PubMed ID: 12352668
    [Abstract] [Full Text] [Related]

  • 17. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
    Shahnavaz SA, Bradley G, Regezi JA, Thakker N, Gao L, Hogg D, Jordan RC.
    Cancer Res; 2001 Mar 15; 61(6):2371-5. PubMed ID: 11289098
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas.
    De Leng WW, Westerman AM, Weterman MA, De Rooij FW, Dekken Hv Hv, De Goeij AF, Gruber SB, Wilson JH, Offerhaus GJ, Giardiello FM, Keller JJ.
    Clin Cancer Res; 2003 Aug 01; 9(8):3065-72. PubMed ID: 12912958
    [Abstract] [Full Text] [Related]

  • 19. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN, Crispin DA, Bronner MP, Dail DH, Hawes SE, Haggitt RC.
    Mod Pathol; 2001 Mar 01; 14(3):139-46. PubMed ID: 11266517
    [Abstract] [Full Text] [Related]

  • 20. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
    Tsiambas E, Karameris A, Gourgiotis S, Salemis N, Athanassiou AE, Karakitsos P, Papalois A, Merikas E, Kosmidis P, Patsouris E.
    J BUON; 2007 Mar 01; 12(2):261-7. PubMed ID: 17600882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.